Literature DB >> 10411010

Dynamic paradigms for human mortality and aging.

K G Manton1.   

Abstract

Hazard models are often applied to mortality data of humans and other species so that the parameter estimates made for those models can be used to make inferences about the biology, and comparative biology, of aging processes. Enough longitudinal data on physiological and functional changes in humans now exist to know that the age trajectory of the physiological state of individuals is multidimensional, stochastic, and plastic. Thus, to fully assess the biological significance of existing longitudinal data on human aging and mortality processes, multivariate stochastic process models must be developed that are biologically detailed and valid. This requires assessing genetic mechanisms controlling human longevity and rates of aging, developing models of how those traits may have evolved, and developing statistical methods for identifying gene environment interactions. This article examines the theoretical basis for such models and the biological rationale of their parametric structure. Several examples are given.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411010     DOI: 10.1093/gerona/54.6.b247

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  3 in total

1.  HEALTHIER, WEALTHIER, AND WISER: A DEMONSTRATION OF COMPOSITIONAL CHANGES IN AGING COHORTS DUE TO SELECTIVE MORTALITY.

Authors:  Anna Zajacova; Sarah A Burgard
Journal:  Popul Res Policy Rev       Date:  2013-06-01

2.  Health, functioning, and disability in older adults--present status and future implications.

Authors:  Somnath Chatterji; Julie Byles; David Cutler; Teresa Seeman; Emese Verdes
Journal:  Lancet       Date:  2014-11-06       Impact factor: 79.321

3.  Socially disparate trends in lifespan variation: a trend study on income and mortality based on nationwide Danish register data.

Authors:  Henrik Brønnum-Hansen
Journal:  BMJ Open       Date:  2017-05-17       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.